Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brook K Baker

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Expert Opinion on Therapeutic Patents|February 24, 2015
Will the Modi government succumb to US and industry pressure to modify its pro-access pharmaceutical patent policy?Brook K Baker
Plos Medicine|March 9, 2016
Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and ElsewhereBrook K Baker
International Journal of Health Services : Planning, Administration, Evaluation|May 6, 2010
The impact of the International Monetary Fund's macroeconomic policies on the AIDS pandemicBrook K Baker
Journal of Pharmaceutical Policy and Practice|July 4, 2017
Data exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union: <i>A proposal for greater coherence in European pharmaceutical legislation</i>Ellen F M 't Hoen, Pascale Boulet, Brook K Baker
Globalization and Health|March 28, 2008
The 'diagonal' approach to Global Fund financing: a cure for the broader malaise of health systems?Gorik Ooms, Wim Van Damme, Brook K Baker, et al.
BMJ Global Health|January 17, 2023
Pandemic preparedness and response: beyond the Access to COVID-19 Tools AcceleratorAbha Saxena, Brook K Baker, Amanda Banda, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Expert Opinion on Therapeutic Patents|February 24, 2015
Will the Modi government succumb to US and industry pressure to modify its pro-access pharmaceutical patent policy?Brook K Baker
Plos Medicine|March 9, 2016
Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and ElsewhereBrook K Baker
International Journal of Health Services : Planning, Administration, Evaluation|May 6, 2010
The impact of the International Monetary Fund's macroeconomic policies on the AIDS pandemicBrook K Baker
Journal of Pharmaceutical Policy and Practice|July 4, 2017
Data exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union: <i>A proposal for greater coherence in European pharmaceutical legislation</i>Ellen F M 't Hoen, Pascale Boulet, Brook K Baker
Globalization and Health|March 28, 2008
The 'diagonal' approach to Global Fund financing: a cure for the broader malaise of health systems?Gorik Ooms, Wim Van Damme, Brook K Baker, et al.
BMJ Global Health|January 17, 2023
Pandemic preparedness and response: beyond the Access to COVID-19 Tools AcceleratorAbha Saxena, Brook K Baker, Amanda Banda, et al.
Pageof 1